Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 12 | 2019 | 94 | 3.650 |
Why?
|
Polymorphism, Single Nucleotide | 22 | 2016 | 1067 | 2.490 |
Why?
|
Mass Spectrometry | 8 | 2017 | 103 | 1.620 |
Why?
|
Genomics | 3 | 2019 | 84 | 1.480 |
Why?
|
Metabolomics | 3 | 2019 | 54 | 1.330 |
Why?
|
Gas Chromatography-Mass Spectrometry | 3 | 2019 | 28 | 1.310 |
Why?
|
Sequence Analysis, DNA | 11 | 2013 | 137 | 1.260 |
Why?
|
Genome, Human | 10 | 2012 | 132 | 1.220 |
Why?
|
DNA-Binding Proteins | 5 | 2016 | 147 | 1.120 |
Why?
|
DNA | 6 | 2014 | 228 | 1.100 |
Why?
|
Insulin Resistance | 4 | 2021 | 461 | 1.050 |
Why?
|
Nucleic Acid Hybridization | 4 | 2018 | 19 | 1.010 |
Why?
|
Chromatin Immunoprecipitation | 4 | 2018 | 21 | 0.920 |
Why?
|
Chromatin | 5 | 2016 | 25 | 0.850 |
Why?
|
Genotype | 12 | 2019 | 734 | 0.850 |
Why?
|
Papio | 3 | 2019 | 91 | 0.810 |
Why?
|
Algorithms | 7 | 2013 | 496 | 0.790 |
Why?
|
Sirtuins | 1 | 2021 | 20 | 0.790 |
Why?
|
Haplotypes | 10 | 2013 | 220 | 0.790 |
Why?
|
Animals | 27 | 2021 | 7466 | 0.770 |
Why?
|
Proteome | 3 | 2014 | 39 | 0.750 |
Why?
|
Membrane Proteins | 2 | 2016 | 257 | 0.750 |
Why?
|
Lipoproteins | 2 | 2012 | 84 | 0.750 |
Why?
|
Kidney Medulla | 3 | 2018 | 29 | 0.730 |
Why?
|
Serum | 2 | 2019 | 19 | 0.690 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2016 | 18 | 0.670 |
Why?
|
Gene Expression Regulation | 6 | 2015 | 494 | 0.650 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 19 | 0.630 |
Why?
|
Kidney Cortex | 1 | 2018 | 25 | 0.630 |
Why?
|
Metabolome | 1 | 2018 | 36 | 0.620 |
Why?
|
Quantitative Trait Loci | 6 | 2015 | 140 | 0.610 |
Why?
|
Genetic Variation | 5 | 2016 | 245 | 0.610 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 29 | 0.600 |
Why?
|
Humans | 45 | 2019 | 32024 | 0.600 |
Why?
|
Obesity | 9 | 2016 | 1179 | 0.600 |
Why?
|
Databases, Genetic | 2 | 2017 | 37 | 0.580 |
Why?
|
Hearing Loss, Bilateral | 1 | 2016 | 2 | 0.560 |
Why?
|
Body Fat Distribution | 2 | 2016 | 34 | 0.560 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2016 | 22 | 0.560 |
Why?
|
Galactokinase | 1 | 2016 | 1 | 0.550 |
Why?
|
Computational Biology | 5 | 2019 | 91 | 0.550 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2016 | 11 | 0.550 |
Why?
|
Liver | 3 | 2021 | 483 | 0.530 |
Why?
|
Mutation | 2 | 2016 | 488 | 0.530 |
Why?
|
Carrier Proteins | 1 | 2016 | 137 | 0.520 |
Why?
|
Triglycerides | 4 | 2012 | 230 | 0.490 |
Why?
|
Software | 5 | 2007 | 127 | 0.480 |
Why?
|
Fatty Liver | 2 | 2011 | 65 | 0.470 |
Why?
|
Disease Progression | 1 | 2016 | 594 | 0.470 |
Why?
|
Genetic Markers | 5 | 2016 | 124 | 0.470 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2013 | 10 | 0.450 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 3 | 2008 | 33 | 0.450 |
Why?
|
Radiation Hybrid Mapping | 3 | 2004 | 4 | 0.440 |
Why?
|
Ischemic Preconditioning, Myocardial | 1 | 2013 | 3 | 0.440 |
Why?
|
Dogs | 6 | 2007 | 120 | 0.440 |
Why?
|
Mitochondria, Heart | 1 | 2013 | 17 | 0.430 |
Why?
|
Comparative Genomic Hybridization | 1 | 2012 | 6 | 0.430 |
Why?
|
DNA Copy Number Variations | 1 | 2012 | 13 | 0.430 |
Why?
|
Tandem Mass Spectrometry | 2 | 2009 | 60 | 0.420 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 106 | 0.400 |
Why?
|
PPAR gamma | 1 | 2011 | 46 | 0.400 |
Why?
|
Isotope Labeling | 3 | 2008 | 16 | 0.400 |
Why?
|
Fluorescence Resonance Energy Transfer | 2 | 2008 | 7 | 0.390 |
Why?
|
Genetic Techniques | 1 | 2011 | 7 | 0.390 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2011 | 4 | 0.390 |
Why?
|
Protein Tyrosine Phosphatases | 4 | 2005 | 17 | 0.370 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 41 | 0.370 |
Why?
|
European Continental Ancestry Group | 5 | 2016 | 1169 | 0.370 |
Why?
|
Obesity, Morbid | 1 | 2010 | 73 | 0.350 |
Why?
|
Apolipoproteins | 4 | 2004 | 200 | 0.340 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 94 | 0.340 |
Why?
|
Hearing Loss | 1 | 2009 | 26 | 0.340 |
Why?
|
Models, Genetic | 4 | 2013 | 94 | 0.330 |
Why?
|
Genetic Testing | 1 | 2009 | 96 | 0.330 |
Why?
|
Biological Assay | 1 | 2009 | 19 | 0.330 |
Why?
|
Clinical Laboratory Techniques | 1 | 2009 | 24 | 0.330 |
Why?
|
Down Syndrome | 1 | 2008 | 14 | 0.320 |
Why?
|
Genome-Wide Association Study | 3 | 2016 | 549 | 0.320 |
Why?
|
Statistics as Topic | 1 | 2009 | 108 | 0.320 |
Why?
|
Y Chromosome | 2 | 1999 | 43 | 0.320 |
Why?
|
Polymerase Chain Reaction | 7 | 2014 | 197 | 0.310 |
Why?
|
Linkage Disequilibrium | 7 | 2012 | 186 | 0.310 |
Why?
|
Databases, Nucleic Acid | 1 | 2007 | 5 | 0.310 |
Why?
|
Male | 20 | 2019 | 19195 | 0.310 |
Why?
|
Gene Frequency | 6 | 2011 | 220 | 0.300 |
Why?
|
Chromosomes, Artificial, Bacterial | 3 | 2004 | 8 | 0.290 |
Why?
|
Rats | 8 | 2013 | 1596 | 0.290 |
Why?
|
Alleles | 5 | 2013 | 248 | 0.280 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2006 | 19 | 0.280 |
Why?
|
Female | 19 | 2019 | 19953 | 0.280 |
Why?
|
Endothelial Cells | 4 | 2008 | 189 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 6 | 2016 | 835 | 0.270 |
Why?
|
Hypertension | 4 | 2010 | 957 | 0.270 |
Why?
|
Saccharomyces cerevisiae | 2 | 2016 | 20 | 0.260 |
Why?
|
Adult | 9 | 2016 | 9366 | 0.250 |
Why?
|
Feeding Behavior | 1 | 2006 | 161 | 0.250 |
Why?
|
Chromatography, Liquid | 4 | 2008 | 43 | 0.250 |
Why?
|
Multigene Family | 2 | 2004 | 51 | 0.250 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2004 | 24 | 0.240 |
Why?
|
Oxygen Isotopes | 4 | 2008 | 7 | 0.230 |
Why?
|
Middle Aged | 11 | 2016 | 11868 | 0.230 |
Why?
|
Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
Lipids | 3 | 2013 | 229 | 0.220 |
Why?
|
Diet | 2 | 2021 | 386 | 0.220 |
Why?
|
Pesticides | 1 | 2016 | 200 | 0.220 |
Why?
|
Occupational Exposure | 1 | 2016 | 233 | 0.220 |
Why?
|
Cohort Studies | 6 | 2016 | 1831 | 0.210 |
Why?
|
Genetic Loci | 2 | 2016 | 146 | 0.210 |
Why?
|
Transients and Migrants | 1 | 2016 | 291 | 0.210 |
Why?
|
Histones | 2 | 2014 | 53 | 0.210 |
Why?
|
Emigrants and Immigrants | 1 | 2016 | 245 | 0.210 |
Why?
|
Chromosome Mapping | 7 | 2007 | 193 | 0.210 |
Why?
|
Promoter Regions, Genetic | 4 | 2016 | 208 | 0.210 |
Why?
|
Random Amplified Polymorphic DNA Technique | 2 | 1999 | 3 | 0.210 |
Why?
|
Cluster Analysis | 3 | 2008 | 128 | 0.200 |
Why?
|
Adipocytes | 2 | 2016 | 80 | 0.200 |
Why?
|
Fructose | 1 | 2021 | 11 | 0.200 |
Why?
|
Organ Specificity | 2 | 2019 | 80 | 0.200 |
Why?
|
Transcription Factors | 3 | 2014 | 180 | 0.190 |
Why?
|
Protein Binding | 3 | 2016 | 201 | 0.190 |
Why?
|
Pedigree | 4 | 2016 | 140 | 0.180 |
Why?
|
Insulin | 3 | 2013 | 366 | 0.180 |
Why?
|
Sequence Tagged Sites | 4 | 2004 | 5 | 0.170 |
Why?
|
Reproducibility of Results | 4 | 2007 | 765 | 0.170 |
Why?
|
Protein Processing, Post-Translational | 3 | 2011 | 78 | 0.170 |
Why?
|
Hispanic Americans | 1 | 2016 | 942 | 0.170 |
Why?
|
Magnetic Field Therapy | 1 | 2019 | 17 | 0.170 |
Why?
|
Carnivora | 1 | 1999 | 2 | 0.170 |
Why?
|
Calcium Channels, T-Type | 1 | 2019 | 29 | 0.170 |
Why?
|
Cholesterol, Dietary | 1 | 2019 | 36 | 0.160 |
Why?
|
Apolipoproteins A | 3 | 2003 | 25 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 61 | 0.160 |
Why?
|
Dyslipidemias | 2 | 2009 | 53 | 0.160 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2007 | 161 | 0.160 |
Why?
|
Genes, Dominant | 2 | 2016 | 27 | 0.150 |
Why?
|
Nuclear Proteins | 1 | 1998 | 74 | 0.150 |
Why?
|
Reference Standards | 1 | 2017 | 32 | 0.150 |
Why?
|
Cell Membrane | 2 | 2008 | 96 | 0.150 |
Why?
|
Liver Neoplasms | 1 | 2019 | 159 | 0.150 |
Why?
|
Calcium | 1 | 2019 | 307 | 0.150 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2016 | 8 | 0.140 |
Why?
|
Adiponectin | 2 | 2013 | 106 | 0.130 |
Why?
|
Lod Score | 2 | 2013 | 72 | 0.130 |
Why?
|
Molecular Sequence Data | 4 | 2007 | 356 | 0.130 |
Why?
|
Peptides | 2 | 2007 | 119 | 0.130 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 20 | 0.130 |
Why?
|
Wisconsin | 2 | 2012 | 21 | 0.130 |
Why?
|
Receptor, Melanocortin, Type 1 | 2 | 2007 | 6 | 0.130 |
Why?
|
Cholesterol | 4 | 2019 | 251 | 0.130 |
Why?
|
Asian Continental Ancestry Group | 2 | 2005 | 108 | 0.120 |
Why?
|
Genetics, Population | 2 | 2005 | 32 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2007 | 104 | 0.120 |
Why?
|
Cell Differentiation | 1 | 2016 | 468 | 0.120 |
Why?
|
Human Genome Project | 3 | 2003 | 3 | 0.120 |
Why?
|
Young Adult | 3 | 2016 | 2615 | 0.120 |
Why?
|
Computer Graphics | 1 | 2013 | 10 | 0.110 |
Why?
|
DNA Primers | 3 | 2005 | 90 | 0.110 |
Why?
|
Apolipoproteins C | 2 | 2003 | 4 | 0.110 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2013 | 8 | 0.110 |
Why?
|
Rats, Wistar | 1 | 2013 | 79 | 0.110 |
Why?
|
Adolescent | 3 | 2016 | 3526 | 0.110 |
Why?
|
London | 1 | 2012 | 2 | 0.110 |
Why?
|
Endocrinology | 1 | 2012 | 2 | 0.110 |
Why?
|
Egypt | 1 | 2012 | 13 | 0.110 |
Why?
|
Atherosclerosis | 1 | 2019 | 767 | 0.110 |
Why?
|
Phenotype | 5 | 2016 | 639 | 0.110 |
Why?
|
Neoplasms | 1 | 2019 | 692 | 0.110 |
Why?
|
History, 20th Century | 1 | 2012 | 71 | 0.100 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 104 | 0.100 |
Why?
|
Amino Acid Sequence | 3 | 2011 | 283 | 0.100 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2001 | 40 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 7 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2012 | 146 | 0.100 |
Why?
|
Phosphopeptides | 1 | 2011 | 3 | 0.100 |
Why?
|
Ions | 1 | 2011 | 12 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 27 | 0.100 |
Why?
|
Caseins | 1 | 2011 | 14 | 0.100 |
Why?
|
Electrophoresis, Agar Gel | 2 | 2004 | 14 | 0.100 |
Why?
|
Trypsin | 2 | 2008 | 11 | 0.100 |
Why?
|
Prospective Studies | 1 | 2016 | 2283 | 0.090 |
Why?
|
Aged, 80 and over | 2 | 2016 | 4000 | 0.090 |
Why?
|
Amidohydrolases | 1 | 2009 | 8 | 0.090 |
Why?
|
Aged | 3 | 2016 | 10340 | 0.090 |
Why?
|
Computer Simulation | 2 | 2013 | 221 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 1125 | 0.090 |
Why?
|
Neonatal Screening | 1 | 2009 | 12 | 0.090 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 35 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 323 | 0.080 |
Why?
|
Case-Control Studies | 2 | 2016 | 897 | 0.080 |
Why?
|
Comorbidity | 1 | 2010 | 569 | 0.080 |
Why?
|
Lectins | 1 | 2008 | 10 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2008 | 16 | 0.080 |
Why?
|
Blotting, Southern | 2 | 1999 | 24 | 0.080 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2005 | 18 | 0.080 |
Why?
|
Horses | 2 | 2005 | 13 | 0.080 |
Why?
|
Complex Mixtures | 1 | 2008 | 3 | 0.080 |
Why?
|
Myoglobin | 2 | 2005 | 11 | 0.080 |
Why?
|
Cells, Cultured | 2 | 2008 | 833 | 0.080 |
Why?
|
Cattle | 1 | 2008 | 103 | 0.080 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2008 | 56 | 0.080 |
Why?
|
Chromatography, Affinity | 1 | 2007 | 15 | 0.080 |
Why?
|
Immunoprecipitation | 1 | 2007 | 33 | 0.080 |
Why?
|
Base Sequence | 3 | 2011 | 251 | 0.080 |
Why?
|
Staining and Labeling | 1 | 2007 | 60 | 0.080 |
Why?
|
Body Mass Index | 3 | 2008 | 923 | 0.070 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2007 | 14 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 27 | 0.070 |
Why?
|
Chromosome Segregation | 1 | 2007 | 3 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 21 | 0.070 |
Why?
|
Hair Color | 1 | 2007 | 3 | 0.070 |
Why?
|
Chloroform | 1 | 2007 | 1 | 0.070 |
Why?
|
Pigmentation | 2 | 2007 | 6 | 0.070 |
Why?
|
Cell Hypoxia | 1 | 2007 | 40 | 0.070 |
Why?
|
Epistasis, Genetic | 1 | 2007 | 44 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2008 | 156 | 0.070 |
Why?
|
Proteins | 1 | 2008 | 145 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 411 | 0.070 |
Why?
|
Infant, Newborn | 1 | 2009 | 673 | 0.070 |
Why?
|
Peptide Hormones | 1 | 2006 | 11 | 0.070 |
Why?
|
Environment | 1 | 2006 | 54 | 0.070 |
Why?
|
Mice | 3 | 2019 | 2475 | 0.070 |
Why?
|
Flap Endonucleases | 1 | 2005 | 1 | 0.060 |
Why?
|
Models, Biological | 1 | 2007 | 391 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2019 | 1017 | 0.060 |
Why?
|
Rabbits | 1 | 2005 | 196 | 0.060 |
Why?
|
Gene Components | 1 | 2004 | 3 | 0.060 |
Why?
|
Japan | 1 | 2004 | 17 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2005 | 111 | 0.060 |
Why?
|
Recombination, Genetic | 1 | 2004 | 22 | 0.060 |
Why?
|
China | 1 | 2004 | 50 | 0.060 |
Why?
|
African Continental Ancestry Group | 1 | 2005 | 363 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2005 | 85 | 0.060 |
Why?
|
Allelic Imbalance | 1 | 2004 | 6 | 0.060 |
Why?
|
Hyperlipidemia, Familial Combined | 1 | 2003 | 3 | 0.060 |
Why?
|
Learning | 1 | 2004 | 79 | 0.060 |
Why?
|
Apolipoprotein A-I | 1 | 2003 | 68 | 0.060 |
Why?
|
Genetics, Medical | 1 | 2003 | 3 | 0.060 |
Why?
|
Leukocytes | 2 | 2013 | 59 | 0.050 |
Why?
|
Fibrosis | 1 | 2003 | 118 | 0.050 |
Why?
|
Biotechnology | 1 | 2002 | 6 | 0.050 |
Why?
|
Angiotensin II | 1 | 2003 | 243 | 0.050 |
Why?
|
Contig Mapping | 1 | 2001 | 3 | 0.050 |
Why?
|
North Carolina | 1 | 2016 | 1516 | 0.050 |
Why?
|
Physical Chromosome Mapping | 1 | 2001 | 8 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2013 | 508 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2003 | 231 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2001 | 23 | 0.050 |
Why?
|
Child | 1 | 2006 | 2441 | 0.040 |
Why?
|
Databases, Factual | 1 | 2001 | 355 | 0.040 |
Why?
|
Asparagine | 1 | 2019 | 6 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2019 | 48 | 0.040 |
Why?
|
Radiometry | 1 | 2019 | 39 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 77 | 0.040 |
Why?
|
Foxes | 1 | 1999 | 1 | 0.040 |
Why?
|
Hip Dysplasia, Canine | 1 | 1999 | 1 | 0.040 |
Why?
|
Wolves | 1 | 1999 | 1 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2019 | 68 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 114 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 1999 | 21 | 0.040 |
Why?
|
Lactic Acid | 1 | 2019 | 53 | 0.040 |
Why?
|
Iliac Artery | 1 | 2019 | 49 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 1999 | 75 | 0.040 |
Why?
|
Species Specificity | 1 | 1999 | 89 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 114 | 0.040 |
Why?
|
Aorta | 1 | 2019 | 125 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2019 | 99 | 0.040 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 85 | 0.040 |
Why?
|
Sex-Determining Region Y Protein | 1 | 1998 | 5 | 0.040 |
Why?
|
Consensus Sequence | 1 | 1998 | 10 | 0.040 |
Why?
|
Chagas Disease | 1 | 2017 | 7 | 0.040 |
Why?
|
Primates | 1 | 2017 | 104 | 0.040 |
Why?
|
Body Weights and Measures | 2 | 2009 | 24 | 0.040 |
Why?
|
Europe | 2 | 2009 | 83 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2017 | 106 | 0.030 |
Why?
|
Agouti Signaling Protein | 2 | 2007 | 2 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2014 | 8 | 0.030 |
Why?
|
Ribosomes | 1 | 2014 | 10 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 2 | 2008 | 47 | 0.030 |
Why?
|
Blood Pressure | 2 | 2013 | 845 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 766 | 0.030 |
Why?
|
Ethnic Groups | 1 | 2016 | 476 | 0.030 |
Why?
|
A Kinase Anchor Proteins | 1 | 2013 | 3 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2013 | 7 | 0.030 |
Why?
|
Apolipoprotein C-III | 2 | 2003 | 5 | 0.030 |
Why?
|
Myosins | 1 | 2013 | 10 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2013 | 15 | 0.030 |
Why?
|
Cadherins | 1 | 2013 | 26 | 0.030 |
Why?
|
CpG Islands | 1 | 2013 | 45 | 0.030 |
Why?
|
Particle Size | 1 | 2013 | 46 | 0.030 |
Why?
|
Exons | 1 | 2013 | 52 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 57 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 120 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 173 | 0.030 |
Why?
|
Formaldehyde | 1 | 2011 | 11 | 0.030 |
Why?
|
DNA Methylation | 1 | 2013 | 140 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 2011 | 16 | 0.020 |
Why?
|
Exodeoxyribonucleases | 1 | 2011 | 19 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2011 | 87 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2011 | 30 | 0.020 |
Why?
|
Escherichia coli | 1 | 2011 | 87 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2019 | 3317 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2009 | 125 | 0.020 |
Why?
|
Inflammation | 1 | 2013 | 540 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2009 | 104 | 0.020 |
Why?
|
Nuclear Family | 1 | 2008 | 15 | 0.020 |
Why?
|
Carbohydrates | 1 | 2008 | 8 | 0.020 |
Why?
|
Homeostasis | 1 | 2008 | 132 | 0.020 |
Why?
|
Fibroblasts | 1 | 2008 | 112 | 0.020 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2007 | 11 | 0.020 |
Why?
|
Hydrolysis | 1 | 2007 | 35 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 2007 | 45 | 0.020 |
Why?
|
Melanocyte-Stimulating Hormones | 1 | 2007 | 2 | 0.020 |
Why?
|
Chromosomes | 1 | 2007 | 9 | 0.020 |
Why?
|
Time Factors | 2 | 2003 | 2152 | 0.020 |
Why?
|
Microscopy | 1 | 2007 | 26 | 0.020 |
Why?
|
Binding Sites | 1 | 2007 | 130 | 0.020 |
Why?
|
Phosphorylation | 1 | 2007 | 230 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 594 | 0.020 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2005 | 12 | 0.020 |
Why?
|
Receptors, Ghrelin | 1 | 2005 | 2 | 0.020 |
Why?
|
Body Size | 1 | 2005 | 32 | 0.020 |
Why?
|
Mathematical Computing | 1 | 2004 | 4 | 0.020 |
Why?
|
Energy Intake | 1 | 2005 | 128 | 0.010 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2004 | 15 | 0.010 |
Why?
|
Family Health | 1 | 2004 | 76 | 0.010 |
Why?
|
Regression Analysis | 1 | 2004 | 294 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2005 | 148 | 0.010 |
Why?
|
Rats, Inbred Dahl | 1 | 2003 | 1 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 31 | 0.010 |
Why?
|
Rats, Inbred BN | 1 | 2003 | 31 | 0.010 |
Why?
|
Point Mutation | 1 | 2003 | 27 | 0.010 |
Why?
|
Sodium Chloride, Dietary | 1 | 2003 | 28 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 292 | 0.010 |
Why?
|
Cytogenetic Analysis | 1 | 2001 | 17 | 0.010 |
Why?
|
Blood Glucose | 1 | 2004 | 492 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 745 | 0.010 |
Why?
|
Radiography | 1 | 1999 | 377 | 0.010 |
Why?
|